Merck Sharp & Dohme Research GmbH's Net Worth

$1.18 Billion

Estimate Recalculated Feb 7, 2024 03:59PM EST

Who is Merck Sharp & Dohme Research GmbH?

Merck Sharp & Dohme Research GmbH has an estimated net worth of $1.18 Billion. This is based on reported shares in BeiGene, Ltd..

SEC CIK

Merck Sharp & Dohme Research GmbH's CIK is 0001665244

Past Insider Trading and Trends

2016 was Merck Sharp & Dohme Research GmbH's most active year for acquiring shares with 3 total transactions. Merck Sharp & Dohme Research GmbH's most active month to acquire stocks was the month of January. 2016 was Merck Sharp & Dohme Research GmbH's most active year for disposing of shares, totalling 2 transactions. Merck Sharp & Dohme Research GmbH's most active month to dispose stocks was the month of January. 2016 saw Merck Sharp & Dohme Research GmbH paying a total of $0.00 for 31,589,038 shares, this is the most they've acquired in one year. In 2016 Merck Sharp & Dohme Research GmbH cashed out on 23,646,724 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BeiGene, Ltd. (BGNE) Snapshot price: $148.05

Investor

Merck Sharp & Dohme Research GmbH owns 7,942,314 units of Ordinary Shares which is worth $1,175,859,587.70. In the year 2016 Merck Sharp & Dohme Research GmbH filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
31.59M
31.59M
Feb 8
Form 3
0
0
No matching records found